{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:56:35Z","timestamp":1793487395921,"version":"4.5.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["3627036"],"award-info":[{"award-number":["3627036"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018883","name":"Maurice Wilkins Centre for Molecular Biodiscovery","doi-asserted-by":"publisher","award":["9341-3622506"],"award-info":[{"award-number":["9341-3622506"]}],"id":[{"id":"10.13039\/501100018883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3627092"],"award-info":[{"award-number":["3627092"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3701339"],"award-info":[{"award-number":["3701339"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3703253"],"award-info":[{"award-number":["3703253"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3702870"],"award-info":[{"award-number":["3702870"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012744","name":"Oakley Mental Health Research Foundation","doi-asserted-by":"publisher","award":["3456030"],"award-info":[{"award-number":["3456030"]}],"id":[{"id":"10.13039\/100012744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010445\/1"],"award-info":[{"award-number":["MR\/L010445\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L011093\/1"],"award-info":[{"award-number":["MR\/L011093\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-PPG2014B-7"],"award-info":[{"award-number":["ARUK-PPG2014B-7"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Widespread elevations in brain urea have, in recent years, been reported in certain types of age-related dementia, notably Alzheimer\u2019s disease (AD) and Huntington\u2019s disease (HD). Urea increases in these diseases are substantive, and approximate in magnitude to levels present in uraemic encephalopathy. In AD and HD, elevated urea levels are widespread, and not only in regions heavily affected by neurodegeneration. However, measurements of brain urea have not hitherto been reported in Parkinson\u2019s disease dementia (PDD), a condition which shares neuropathological and symptomatic overlap with both AD and HD. Here we report measurements of tissue urea from nine neuropathologically confirmed regions of the brain in PDD and post-mortem delay (PMD)-matched controls, in regions including the cerebellum, motor cortex (MCX), sensory cortex, hippocampus (HP), substantia nigra (SN), middle temporal gyrus (MTG), medulla oblongata (MED), cingulate gyrus, and pons, by applying ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS\/MS). Urea concentrations were found to be substantively elevated in all nine regions, with average increases of 3\u20134-fold. Urea concentrations were remarkably consistent across regions in both cases and controls, with no clear distinction between regions heavily affected or less severely affected by neuronal loss in PDD. These urea elevations mirror those found in uraemic encephalopathy, where equivalent levels are generally considered to be pathogenic, and those previously reported in AD and HD. Increased urea is a widespread metabolic perturbation in brain metabolism common to PDD, AD, and HD, at levels equal to those seen in uremic encephalopathy. This presents a novel pathogenic mechanism in PDD, which is shared with two other neurodegenerative diseases.<\/jats:p>","DOI":"10.3389\/fnmol.2021.711396","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T07:32:59Z","timestamp":1634887979000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson\u2019s Disease Dementia"],"prefix":"10.3389","volume":"14","author":[{"given":"Melissa","family":"Scholefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Patassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel M.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth J. S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/bpa.12592","article-title":"Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer\u2019s disease pathology.","volume":"28","author":"Alonso-Andres","year":"2018","journal-title":"Brain Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/sj.mp.4002089","article-title":"Evidence for induction of the ornithine transcarbamylase expression in Alzheimer\u2019s disease.","volume":"14","author":"Bensemain","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s11011-017-0105-2","article-title":"In human brain ornithine transcarbamylase (OTC) immunoreactivity is strongly expressed in a small number of nitrergic neurons.","volume":"32","author":"Bernstein","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00726-015-1960-y","article-title":"Possible sources and functions of L-homoarginine in the brain: review of the literature and own findings.","volume":"47","author":"Bernstein","year":"2015","journal-title":"Amino Acids"},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease.","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-27","article-title":"Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.","volume":"3","author":"Colton","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1023\/A:1024255208563","article-title":"Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson\u2019s disease.","volume":"28","author":"Engelborghs","year":"2003","journal-title":"Neurochem. Res."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical Neurology and epidemiology of the major Neurodegenerative Diseases.","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0946-y","article-title":"Brain ureido degenerative protein modifications are associated with neuroinflammation and proteinopathy in Alzheimer\u2019s disease with cerebrovascular disease.","volume":"14","author":"Gallart-Palau","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease.","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Devel, Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.nbd.2019.01.003","article-title":"Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson\u2019s disease.","volume":"124","author":"Glaab","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1073\/pnas.1517096113","article-title":"Protein carbamylation is a hallmark of aging.","volume":"113","author":"Gorisse","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.bbadis.2016.06.007","article-title":"Metabolic signatures of Huntington\u2019s disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain.","volume":"1862","author":"Graham","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","article-title":"Alzheimer\u2019s disease: amino acid levels and brain metabolic status.","volume":"34","author":"Gueli","year":"2013","journal-title":"Neurol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.bbagen.2018.07.030","article-title":"Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils.","volume":"1862","author":"Guru KrishnaKumar","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/mds.27173","article-title":"Profiling novel metabolic biomarkers for Parkinson\u2019s disease using in-depth metabolomic analysis.","volume":"32","author":"Han","year":"2017","journal-title":"Mov. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"E11293","DOI":"10.1073\/pnas.1711243115","article-title":"Brain urea increase is an early Huntington\u2019s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.","volume":"114","author":"Handley","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson\u2019s disease by metabolomic technologies.","volume":"87","author":"Hatano","year":"2016","journal-title":"J. Neurol, Neurosurg. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years.","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-449851-8.00038-3","article-title":"Primary metabolic and renal hyperuricemia","author":"Ichida","year":"2009","journal-title":"Genetic Diseases of the Kidney"},{"key":"B22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies.","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3940(92)90015-Y","article-title":"Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson\u2019s disease.","volume":"145","author":"Iwasaki","year":"1992","journal-title":"Neurosci. Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","article-title":"Is Braak staging valid for all types of Parkinson\u2019s disease?","volume":"126","author":"Jellinger","year":"2019","journal-title":"J. Neural Trans."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2015.04.021","article-title":"A natural compound macelignan protects midbrain dopaminergic neurons from inflammatory degeneration via microglial arginase-1 expression.","volume":"760","author":"Kiyofuji","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","article-title":"Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis.","volume":"20","author":"Kori","year":"2016","journal-title":"OMICS"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer\u2019s disease brains.","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.acc.2018.07.002","article-title":"Protein carbamylation in chronic kidney disease and dialysis.","volume":"87","author":"Long","year":"2018","journal-title":"Adv. Clin. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7831-1_1","article-title":"Overview of mitochondrial bioenergetics.","volume":"1782","author":"Madeira","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0022-510X(97)00119-6","article-title":"Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson\u2019s disease.","volume":"151","author":"Mally","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000346370","article-title":"Postmortem brain levels of urate and precursors in Parkinson\u2019s disease and related disorders.","volume":"12","author":"McFarland","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-510X(97)00069-5","article-title":"Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson\u2019s disease.","volume":"150","author":"Molina","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement.","volume":"37","author":"Nolfi-Donegan","year":"2020","journal-title":"Redox Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbrc.2015.10.140","article-title":"Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington\u2019s disease.","volume":"468","author":"Patassini","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.bbadis.2016.06.002","article-title":"Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington\u2019s disease human brain.","volume":"1862","author":"Patassini","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ana.410440705","article-title":"Alzheimer\u2019s disease and Parkinson\u2019s disease: distinct entities or extremes of a spectrum of neurodegeneration?","volume":"44","author":"Perl","year":"1998","journal-title":"Ann. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","article-title":"L-Norvaline reverses cognitive decline and synaptic loss in a murine model of Alzheimer\u2019s Disease.","volume":"15","author":"Polis","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10110438","article-title":"Effects of alterations of post-mortem delay and other tissue-collection variables on metabolite levels in human and rat brain.","volume":"10","author":"Scholefield","year":"2020","journal-title":"Metabolites"},{"key":"B41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jnen\/nly024","article-title":"Increased oxidative stress exacerbates alpha-synuclein aggregation in vivo.","volume":"77","author":"Scudamore","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-0031-1277984","article-title":"Uremic encephalopathy and other brain disorders associated with renal failure.","volume":"31","author":"Seifter","year":"2011","journal-title":"Semin. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/ki.2014.320","article-title":"Urea for hyponatremia?","volume":"87","author":"Sterns","year":"2015","journal-title":"Kidney Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/mds.27132","article-title":"Distinct metabolomic signature in cerebrospinal fluid in early parkinson\u2019s disease.","volume":"32","author":"Trezzi","year":"2017","journal-title":"Mov. Disord."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1554-x","article-title":"A metabolomic signature of treated and drug-naive patients with Parkinson\u2019s disease: a pilot study.","volume":"15","author":"Troisi","year":"2019","journal-title":"Metabolomics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.semnephrol.2004.06.026","article-title":"Oxidative stress in uremia: nature, mechanisms, and potential consequences.","volume":"24","author":"Vaziri","year":"2004","journal-title":"Semin. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and oxidative stress: the molecular connectivity between insulin resistance. Obesity, and Alzheimer\u2019s Disease.","volume":"2015","author":"Verdile","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/10408398.2011.573885","article-title":"L-arginine and nitric oxide in CNS function and neurodegenerative diseases.","volume":"53","author":"Virarkar","year":"2013","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","article-title":"Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies - current issues and future directions.","volume":"150","author":"Walker","year":"2019","journal-title":"J Neurochem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ebiom.2019.09.049","article-title":"High urea induces depression and LTP impairment through mTOR signalling suppression caused by carbamylation.","volume":"48","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuint.2019.02.016","article-title":"Iron-induced oxidative stress contributes to alpha-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.","volume":"125","author":"Wang","year":"2019","journal-title":"Neurochem. Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/C5MB00711A","article-title":"Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson\u2019s disease and control subjects.","volume":"12","author":"Wuolikainen","year":"2016","journal-title":"Mol. Biosyst."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bbadis.2016.03.001","article-title":"Graded perturbations of metabolism in multiple regions of human brain in Alzheimer\u2019s disease: snapshot of a pervasive metabolic disorder.","volume":"1862","author":"Xu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-018-0254-9","article-title":"Regional protein expression in human Alzheimer\u2019s brain correlates with disease severity.","volume":"2","author":"Xu","year":"2019","journal-title":"Commun. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","article-title":"Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.","volume":"62","author":"Yan","year":"2013","journal-title":"Free Radic. Biol. Med."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2021.711396\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T07:33:04Z","timestamp":1634887984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2021.711396\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":56,"alternative-id":["10.3389\/fnmol.2021.711396"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2021.711396","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"article-number":"711396"}}